In this Energy Code Deep Dive episode, Dr. Mike breaks down a provocative neuroprotection review: low-dose methylene blue and near-infrared (NIR) light may look like totally different therapies — one is a molecule, one is photons — but the paper argues they converge on the same core target: mitochondrial respiration. You’ll hear a simple “neurons as cities / mitochondria as power plants” model for neurodegeneration, why methylene blue can function like an alternate electron shuttle in the electron transport chain, how NIR light can energize cytochrome oxidase, and why both approaches may widen the neuron’s “energy margin” during stress. The takeaway isn’t “magic cures.” It’s a disciplined mitochondrial lens: improving the power supply may give repair, plasticity, and survival systems the bandwidth to work.

(Educational content only, not medical advice.)

Article Discussed in Episode:

Protection against neurodegeneration with low-dose methylene blue and near-infrared light

Key Quotes From Dr. Mike:

“Two very different therapies (methylene blue & NIR light) may be helping the brain in basically the same way.”

“Methylene blue, at low doses, appears to help by acting like an alternate electron shuttle.”

“This paper makes the point that methylene blue has a hormetic dose response…”

“…near infrared light is more like directly energizing one of the key turbines in the mitochondrial power plant.”

“Different tools, same target, and that target is mitochondrial respiration.”

“…if you can stabilize mitochondrial respiration, you may be able to widen that energy margin and make neurons harder to kill.”

Key Points

The paper’s thesis: two very different interventions may protect neurons via the same mitochondrial mechanism.
Neurodegeneration framed as energy margin collapse (not only plaques/tangles/toxins/inflammation).
Low-dose methylene blue: acts as an alternate electron shuttle → supports electron flow, ATP production.
Dose matters: methylene blue shows hormesis (low dose supportive; higher dose can backfire).
Near-infrared light: photons absorbed by cytochrome oxidase → boosts mitochondrial respiration and ATP.
NIR effects may outlast a session via enzyme induction / capacity signaling (not just a short “boost”).
Unifying mechanism: both interventions enhance oxidative metabolism and support neuronal survival under stress.
Paper reviews multiple model contexts (ischemia, trauma, neurotoxicity, neurodegeneration models, etc.) as “shared bottleneck” evidence.
Practical translation emphasis: target access matters (MB crosses BBB; NIR can reach cortical tissue with correct parameters).
Key caution: mechanism ≠ guaranteed clinical proof; these are credible mitochondrial-support tools, not universal cures.

Episode timeline

0:19–0:34 — Show open + why this paper matters
0:34–1:20 — Core premise: different tools, same mitochondrial target
1:22–2:24 — “Neuron as a city” model: neurodegeneration as failing power plants
2:24–4:24 — Methylene blue explained: electron transport chain “extra courier” + hormetic dosing
4:24–5:15 — Cytochrome oxidase focus: why boosting the “end-of-line turbine” matters
5:15–7:24 — Near-infrared light mechanism: photons → cytochrome oxidase → ATP + longer-lasting effects
7:24–8:55 — The unifying mechanism: respiration support → wider “energy margin” → neurons harder to kill
8:55–10:29 — Evidence across models + “target access” (BBB penetration; transcranial penetration)
10:29–11:43 — Why energy support unlocks repair/plasticity outputs (BDNF, synaptogenesis, etc.)
11:43–12:34 — Hormesis again: the “sweet spot” principle for MB and light
12:34–15:25 — Synthesis + disciplined conclusion (not cures; mitochondrial respiration is the lever)

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT)

Grounding products: Earthing.com

Stay up-to-date on social media:

Dr. Mike Belkowski:

BioLight: